The TEVAR Center

Filter Your Results




LeMaitre Vascular Commences ENTRUST Trial of TAArget Thoracic Stent Graft

August 6, 2010—LeMaitre Vascular, Inc. (Burlington, MA) announced the initiation of the ENTRUST trial, its clinical investigation of the TAArget thoracic stent graft. Five c…

First Patient Enrolled in Aortic Dissection Trial of Medtronic's Valiant Thoracic Stent Graft

August 5, 2010—Medtronic, Inc. (Minneapolis, MN) announced the enrollment of the first patient in the Medtronic Dissection trial, which is evaluating the clinical performanc…

An Interview With Benjamin W. Starnes, MD

July 2010—Dr. Starnes discusses his military physician training and his closure protocol for EVAR patients.

AHA Issues Scientific Statement on Descending Thoracic Aortic Disease Management

June 29, 2010—In Circulation, Michael A. Coady, MD, et al have published an American Heart Association scientific statement on open and endovascular surgical management of d…

FDA Approves 45-mm Gore TAG

June 7, 2010—W. L. Gore & Associates (Flagstaff, AZ) announced that it has received approval from the US Food and Drug Administration (FDA) to market a 45-mm-diameter ve…

First Patient Treated With Valiant Thoracic Stent Graft in RESCUE Study

May 19, 2010—Medtronic, Inc. (Minneapolis, MN) announced that the first patient has been enrolled in its RESCUE clinical trial. The RESCUE trial will evaluate the safety and…

Cook Initiates European Study of Zenith TX2 Low-Profile TAA Graft

May 12, 2010—Cook Medical (Bloomington, IN) announced the commencement of its European clinical investigation of the Zenith TX2 low-profile thoracic aortic aneurysm (TAA) gr…

FDA Clears Gore’s DrySeal Sheath

May 11, 2010—W. L. Gore & Associates (Flagstaff, AZ) announced US Food and Drug Administration clearance to market the DrySeal sheath. The device is designed to aid in t…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.